Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with Congenital Disorders of Glycosylation (CDG)

被引:52
作者
Rush, JS
Panneerselvam, K
Waechter, CJ
Freeze, HH
机构
[1] Burnham Inst, La Jolla, CA 92037 USA
[2] Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Biochem, Lexington, KY 40536 USA
关键词
GDP-mannose; mannose; Congenital Disorders of Glycosylation (CDG); fibroblast; phosphomannose isomerase;
D O I
10.1093/glycob/10.8.829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Congenital Disorders of Glycosylation (CDC) are human deficiencies in glycoprotein biosynthesis. Previous studies showed that 1 mM mannose corrects defective protein N-glycosylation in cultured fibroblasts from some CDG patients. We hypothesized that these CDG cells have limited GDP-mannose (GDP-Man) and that exogenous mannose increases the GDP-Man levels. Using a well established method to measure GDP-Man, we found that normal fibroblasts had an average of 23.5 pmol GDP-Man/10(6) cells, whereas phosphomannomutase (PMM)-deficient fibroblasts had only 2.3-2.7 pmol/10(6) cells. Adding 1 mM mannose to the culture medium increased the GDP-Man level in PMM-deficient cells to approximately 15.5 pmol/10(6) cells, but had no significant effect on GDP-Man levels in normal fibroblasts. Similarly, mannose supplementation increased GDP-Man from 4.6 pmol/10(6) cells to 24.6 pmol/10(6) cells in phosphomannose isomerase (PMI)-deficient fibroblasts, Based on the specific activity of the GDP[H-3]Man pool present in [2-H-3]mannose labeled cells, mannose supplementation also partially corrected the impaired synthesis of mannosylphosphoryldolichol (Man-P-Dol) and Glc(0.3)Man(9)GlcNAc(2)-P-P-Dol. These results confirm directly that deficiencies in PMM and PMI result in lowered cellular GDP-Man levels that are corrected by the addition of mannose, In contrast to these results, GDP-Man levels in fibroblasts from a CDG-Ie patient, who is deficient in Man-P-Dol synthase, were normal and unaffected by mannose supplementation even though mannose addition was found to correct abnormal lipid intermediate synthesis in another study (Kim et al, [2000] J, Clin, Invest., 105, 191-198). The mechanism by which mannose supplementation corrects abnormal protein N-glycosylation in Man-P-Dol synthase deficient cells is unknown, but this observation suggests that the regulation of Man-P-Dol synthesis and utilization may be more complex than is currently understood.
引用
收藏
页码:829 / 835
页数:7
相关论文
共 44 条
[1]   A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide [J].
Burda, P ;
Borsig, L ;
de Rijk-van Andel, J ;
Wevers, R ;
Jaeken, J ;
Carchon, H ;
Berger, EG ;
Aebi, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :647-652
[2]   Intracellular signaling from the endoplasmic reticulum to the nucleus [J].
Chapman, R ;
Sidrauski, C ;
Walter, P .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :459-485
[3]  
CUMMINGS RD, 1992, GLYCOCONJUGATES COMP, P333
[4]  
DATEMA R, 1981, J BIOL CHEM, V256, P1191
[5]   A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency [J].
de Koning, TJ ;
Dorland, L ;
van Diggelen, OP ;
Boonman, AMC ;
de Jong, GJ ;
van Noort, WL ;
De Schryver, J ;
Duran, M ;
van den Berg, IET ;
Gerwig, GJ ;
Berger, R ;
Poll-The, BT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) :38-42
[6]   Regulation of the dolichol pathway in human fibroblasts by the endoplasmic reticulum unfolded protein response [J].
Doerrler, WT ;
Lehrman, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13050-13055
[7]   Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity [J].
Freeze, HH ;
Aebi, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3) :167-178
[8]   Disorders in protein glycosylation and potential therapy: Tip of an iceberg? [J].
Freeze, HH .
JOURNAL OF PEDIATRICS, 1998, 133 (05) :593-600
[9]   Human glycosylation disorders and sugar supplement therapy [J].
Freeze, HH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) :189-193
[10]  
GERSHMAN H, 1981, J BIOL CHEM, V256, P7774